Company / R&D Expense
Core Scientific, Inc./tx R&D Expense History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$11.8M
FY2024
5-year range
$7.2M / $27.0M
FY2020-FY2024
Trend
+64.7%
vs FY2023
Sector context
#17 of 20
Financials
What the data says
Core Scientific, Inc./tx's r&d expense of $12M is lower than 85% of companies in the Financials sector (FY2024). Declined from $27M to $12M over the past 2 years.
Based on SEC 10-K filings.
$12M in FY2024 with a 3-year CAGR of +15.5%.
Declined from $27M to $12M over the past 2 years.
Financials sector context is included.
R&D Expense over time
Growth rates
- 3-Year CAGR
- +15.5%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 15% in FinancialsTop 85% of 20This company $11.8M Sector average $402.2M
▼
-97.1% below sector average
Key checks
Key Insights
- 3-year CAGR of +15.5%, indicating consistent growth.
- In FY2024, r&d expense increased 64.7% year-over-year.
- Ranks #17 out of 20 companies in the Financials sector.
- Peak r&d expense was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score -1.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $11.8M | +64.7% |
| FY2023 | $7.2M | -73.4% |
| FY2022 | $27.0M | +251.3% |
| FY2021 | $7.7M | +45.6% |
| FY2020 | $5.3M | - |
As of FY2024 · SEC 10-K · Updated Mar 29, 2026